ID   CaCL 73-36
AC   CVCL_T324
AS   CVCL_D033
SY   CaCL73-36; CM73-36; M-6; M6
DR   cancercelllines; CVCL_T324
DR   ESTDAB; ESTDAB-132
DR   GEO; GSM202137
DR   IGRhCellID; M6%20GEO
DR   Progenetix; CVCL_T324
DR   Wikidata; Q54808313
RX   PubMed=944091;
RX   PubMed=1010531;
RX   PubMed=1127734;
RX   PubMed=3558490;
RX   PubMed=3800326;
RX   PubMed=7262181;
RX   PubMed=9268730;
RX   PubMed=10851482;
CC   Doubling time: 34 hours (PubMed=1127734).
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): ESTDAB=ESTDAB-132
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D3S1358: 17,18
ST   D5S818: 11,13
ST   D7S820: 9,10
ST   FGA: 23,23.2
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 15,17
DI   NCIt; C3510; Cutaneous melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   50Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 02-05-24; Version: 14
//
RX   PubMed=944091;
RA   McCulloch P.B., Dent P.B., Hayes P.R., Liao S.-K.;
RT   "Common and individually specific chromosomal characteristics of
RT   cultured human melanoma.";
RL   Cancer Res. 36:398-404(1976).
//
RX   PubMed=1010531; DOI=10.1007/BF02797466;
RA   Liao S.-K., Dent P.B., McCulloch P.B.;
RT   "Cellular morphology of human malignant melanoma in primary culture.";
RL   In Vitro 12:654-657(1976).
//
RX   PubMed=1127734; DOI=10.1093/jnci/54.5.1037;
RA   Liao S.-K., Dent P.B., McCulloch P.B.;
RT   "Characterization of human maligant melanoma cell lines. I. Morphology
RT   and growth characteristics in culture.";
RL   J. Natl. Cancer Inst. 54:1037-1044(1975).
//
RX   PubMed=3558490; DOI=10.1002/jcp.1041300303;
RA   Gupta R.S., Dudani A.K.;
RT   "Species-specific differences in the toxicity of rhodamine 123 towards
RT   cultured mammalian cells.";
RL   J. Cell. Physiol. 130:321-327(1987).
//
RX   PubMed=3800326;
RA   Kawakubo Y., Liao S.-K.;
RT   "Enhanced expression of HLA-DR antigens by the human melanoma cell
RT   line CaCL 73-36 upon induction of a less differentiated phenotype with
RT   bromodeoxyuridine.";
RL   Anticancer Res. 6:1197-1204(1986).
//
RX   PubMed=7262181; DOI=10.1002/eji.1830110603;
RA   Liao S.-K., Clarke B.J., Kwong P.C., Brickenden A., Gallie B.L.,
RA   Dent P.B.;
RT   "Common neuroectodermal antigens on human melanoma, neuroblastoma,
RT   retinoblastoma, glioblastoma and fetal brain revealed by hybridoma
RT   antibodies raised against melanoma cells.";
RL   Eur. J. Immunol. 11:450-454(1981).
//
RX   PubMed=9268730; DOI=10.1006/bbrc.1997.7157;
RA   Cheng A.-J., Liao S.-K., Chow S.-E., Chen J.-K., Wang T.-C.V.;
RT   "Differential inhibition of telomerase activity during induction of
RT   differentiation in hematopoietic, melanoma, and glioma cells in
RT   culture.";
RL   Biochem. Biophys. Res. Commun. 237:438-444(1997).
//
RX   PubMed=10851482; DOI=10.1089/cbr.1997.12.317;
RA   Perng Y.-P., Lin C.-C., Perng I.-M., Shen Y.-C., Chuang C.-K.,
RA   Liao S.-K.;
RT   "Culture medium induced morphological changes of melanoma cells
RT   associated with change in sensitivity to lysis by lymphokine-activated
RT   killer cells.";
RL   Cancer Biother. Radiopharm. 12:317-331(1997).
//